Boryung

보령 · 003850

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$535.2M (₩738.6B)

Overview

Boryung is a South Korean pharmaceutical company that develops and supplies prescription and over-the-counter medicines to patients and healthcare providers.

Its products are distributed through hospitals, clinics, and pharmacies in Korea. Listed on KOSPI, Korea's main stock exchange, the company conducts its own research and development activities alongside its commercial pharmaceutical business.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$737.3M

Operating profit · FY2025

US$47.1M

▼ −7.7% YoY

Net income · FY2025

US$46.6M

▼ −7.7% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$622.9M(₩859.6B)	US$737M(₩1T)	US$737.3M(₩1T)
Operating profit	US$49.5M(₩68.3B)	US$51.1M(₩70.5B)	US$47.1M(₩65.1B)
Net income	US$29.1M(₩40.2B)	US$50.5M(₩69.6B)	US$46.6M(₩64.3B)

Revenue

FY2023US$622.9M
FY2024US$737M
FY2025US$737.3M

Operating profit

FY2023US$49.5M
FY2024US$51.1M
FY2025US$47.1M

Net income

FY2023US$29.1M
FY2024US$50.5M
FY2025US$46.6M

Key ratios (FY2025)

ROE

7.6%

Debt/Eq

64.2%

Op. margin

6.4%

Net margin

6.3%

Rev. YoY

0.0%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?